Methods
T2D, type 2 diabetes, RA
PATHOLOGY, TYPE 2 DIABETES, RECRUITMENT, APPENDIX
GP-OSMOTIC was a two-arm, open label, 12-month individually randomised controlled trial across 25 general practices in Victoria, Australia. The target population was adults (aged ≥ 18 years) with type 2 diabetes (T2D) whose HbA1c was above recommended target, despite prescription of at least two non-insulin hypoglycaemic agents and/or insulin. The intervention involved the use of a professional-mode flash glucose monitoring system and patients in the control arm received usual clinical care. The study design, its findings and cost-effectiveness have been reported in detail [Practices were selected from a database of research and teaching active practices associated with the Department of General Practice at the University of Melbourne. Those with at least one consenting general practitioner are eligible to be part of the trial. Practices generated a list of potentially eligible people with T2D to be screened for full eligibility by searching their practice electronic medical record (EMR) database or using an audit tool. People with T2D were invited by letter and/or telephone call to attend the practice to hear more about the study and if interested to give consent. After consenting, a clinically trained research assistant (RA) collected baseline data and arranged baseline pathology tests. Study data collection and randomisation were managed using REDCap [A questionnaire was prospectively developed to capture details relating to study site and recruitment and was completed for each study site. The questionnaire included three sections (Appendix 